Guggulsterone ameliorates ethidium bromide-induced experimental model of multiple sclerosis via restoration of behavioral, molecular, neurochemical and …

N Kumar, N Sharma, R Khera, R Gupta… - Metabolic brain disease, 2021 - Springer
Multiple Sclerosis (MS) is a progressive neurodegenerative disease with clinical signs of
neuroinflammation and the central nervous system's demyelination. Numerous studies have …

Non-receptor tyrosine kinase signaling in autoimmunity and therapeutic implications

S Solouki, A August, W Huang - Pharmacology & therapeutics, 2019 - Elsevier
Autoimmune diseases are characterized by impaired immune tolerance towards self-
antigens, leading to enhanced immunity to self by dysfunctional B cells and/or T cells. The …

Tergitol@ SiO2@ Fe3O4 magnetic nano-material and experimental design methodology: An effective and selective adsorbent for solid phase microextraction and …

N Altunay, A Elik, G Sarp, E Yılmaz, HI Ulusoy - Microchemical Journal, 2021 - Elsevier
In current paper, we synthesized a new and functional magnetic Tergitol@ SiO 2@ Fe 3 O 4.
The synthesized magnetic nano-material was characterized in detail using transmission …

STAT5a and STAT6 gene expression levels in multiple sclerosis patients

M Hatami, T Salmani, S Arsang-Jang, MD Omrani… - Cytokine, 2018 - Elsevier
Multiple sclerosis (MS) is a complex inflammatory, autoimmune disease of the central
nervous system (CNS). The disease pathogenesis is not well defined yet. Cytokines have an …

[HTML][HTML] Dietary therapy in secondary progressive multiple sclerosis: a case report

J Nathan, DK Kale, VD Naik, F Thakker, S Bailur - Cureus, 2019 - ncbi.nlm.nih.gov
A 60-year-old man presented with a history of an acute episode of mono-ocular involvement
and several acute spinal cord episodes from 1988 to 1991. Multiple MRIs of the spinal cord …

[HTML][HTML] An unsupervised computational pipeline identifies potential repurposable drugs to treat Huntington's disease and multiple sclerosis

L Menestrina, M Recanatini - Artificial Intelligence in the Life Sciences, 2022 - Elsevier
Drug repurposing consists in identifying additional uses for known drugs and, since these
new findings are built on previous knowledge, it reduces both the length and the costs of the …

A Simple Computational Approach to Identify Potential Drugs for Multiple Sclerosis and Cognitive Disorders from Expert Curated Resources

K Raja, A Prabahar, SS Arputhanatham - Biomedical Text Mining, 2022 - Springer
Multiple sclerosis, a disease of central nervous system leads to potential disability. In the
USA, one million cases are diagnosed with multiple sclerosis in 2019. Multiple sclerosis is …

Quantitative image analysis in some iron powder metallurgy materials

M Marin, FB Marin - IOP Conference Series: Materials Science …, 2019 - iopscience.iop.org
The goal of the present paper is to analyze the porosity in some powder metallurgy (P/M)
alloys by two different methods, using the conventional method and by image processing …

[PDF][PDF] TERAPIA ASISTIDA POR ANIMALES (TAA) y su aplicación en contextos hospitalarios: una revisión de la literatura.

J Lecuona - Recuperado de https://revistas. upb. edu. co/index. php … - matiainstituto.net
Un vínculo se caracteriza por una interacción afectiva especial y duradera con un individuo
único, no intercambiable con otro (Ainsworth, 1991; Carrillo y Gutiérrez, 2000). Esta …

[引用][C] New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata

R Erçoban, ZGK İslamoğlu - Dermatologic therapy, 2022 - pubmed.ncbi.nlm.nih.gov
New developing multiple sclerosis in a patient using tofacitinib due to alopesia areata New
developing multiple sclerosis in a patient using tofacitinib due to alopesia areata Dermatol Ther …